Biotechnology company Concord Biotech will be the first amongst them, planning to raise Rs 1,550.6 crore via maiden public issue. It is from the mainboard segment.
Biotechnology company Concord Biotech will be the first amongst them, planning to raise Rs 1,550.6 crore via maiden public issue. It is from the mainboard segment. Biotechnology company Concord Biotech will be the first amongst them, planning to raise Rs 1,550.6 crore via maiden public issue. It is from the mainboard segment. Moneycontrol Latest News Read More